Aveanna Healthcare Reports Q3 EPS of $0.20, Revenue of $695.5 Million, Both Results Beat Estimates
Adjusted EBITDA climbs 25% year over year, full-year guidance raised Related Stocks: AVAH ,
Adjusted EBITDA climbs 25% year over year, full-year guidance raised Related Stocks: AVAH ,